Arrowstreet Capital’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.07M | Sell |
84,435
-29,417
| -26% | -$1.37M | ﹤0.01% | 1217 |
|
|
2025
Q4 | $5.52M | Buy |
113,852
+96,346
| +550% | +$4.78M | ﹤0.01% | 1107 |
|
|
2025
Q3 | $826K | Sell |
17,506
-658
| -4% | -$31.8K | ﹤0.01% | 1631 |
|
|
2025
Q2 | $878K | Sell |
18,164
-828,251
| -98% | -$42.3M | ﹤0.01% | 1645 |
|
|
2025
Q1 | $46.9M | Buy |
846,415
+566,522
| +202% | +$30.7M | 0.04% | 380 |
|
|
2024
Q4 | $13.5M | Sell |
279,893
-61,971
| -18% | -$3.15M | 0.01% | 727 |
|
|
2024
Q3 | $21.9M | Buy |
341,864
+25,452
| +8% | +$1.37M | 0.02% | 521 |
|
|
2024
Q2 | $15.4M | Buy |
316,412
+147,221
| +87% | +$7.1M | 0.01% | 534 |
|
|
2024
Q1 | $8.22M | Buy |
169,191
+55,518
| +49% | +$2.71M | 0.01% | 741 |
|
|
2023
Q4 | $5.65M | Sell |
113,673
-465,675
| -80% | -$22.8M | 0.01% | 715 |
|
|
2023
Q3 | $31.1M | Sell |
579,348
-241,122
| -29% | -$12.9M | 0.04% | 311 |
|
|
2023
Q2 | $44.2M | Sell |
820,470
-1,516,382
| -65% | -$81.6M | 0.05% | 269 |
|
|
2023
Q1 | $127M | Sell |
2,336,852
-1,089,377
| -32% | -$53M | 0.16% | 142 |
|
|
2022
Q4 | $166M | Sell |
3,426,229
-573,617
| -14% | -$25.2M | 0.23% | 117 |
|
|
2022
Q3 | $152M | Buy |
3,999,846
+248,615
| +7% | +$11.1M | 0.22% | 113 |
|
|
2022
Q2 | $188M | Buy |
3,751,231
+389,119
| +12% | +$20.7M | 0.27% | 103 |
|
|
2022
Q1 | $173M | Buy |
3,362,112
+2,468,271
| +276% | +$127M | 0.22% | 122 |
|
|
2021
Q4 | $44.8M | Buy |
893,841
+73,090
| +9% | +$3.62M | 0.05% | 307 |
|
|
2021
Q3 | $39.6M | Buy |
820,751
+323,503
| +65% | +$16.4M | 0.05% | 366 |
|
|
2021
Q2 | $26.2M | Sell |
497,248
-914,417
| -65% | -$47.7M | 0.03% | 511 |
|
|
2021
Q1 | $69.8M | Buy |
1,411,665
+353,665
| +33% | +$17M | 0.09% | 213 |
|
|
2020
Q4 | $51.4M | Sell |
1,058,000
-6,500
| -0.6% | -$321K | 0.07% | 272 |
|
|
2020
Q3 | $53.4M | Sell |
1,064,500
-39,314
| -4% | -$2.02M | 0.08% | 223 |
|
|
2020
Q2 | $56.4M | Sell |
1,103,814
-89,838
| -8% | -$4.37M | 0.1% | 178 |
|
|
2020
Q1 | $52.2M | Buy |
+1,193,652
| New | +$57.1M | 0.15% | 139 |
|
|
2019
Q3 | – | Sell |
-1,043,595
| Closed | -$45.2M | – | 1699 |
|
|
2019
Q2 | $45.2M | Buy |
1,043,595
+43,792
| +4% | +$1.86M | 0.1% | 206 |
|
|
2019
Q1 | $44.3M | Buy |
999,803
+350,218
| +54% | +$15M | 0.1% | 206 |
|
|
2018
Q4 | $28.2M | Buy |
649,585
+643,585
| +10,726% | +$28.4M | 0.07% | 251 |
|
|
2018
Q3 | $268K | Sell |
6,000
-889,452
| -99% | -$38M | ﹤0.01% | 993 |
|
|
2018
Q2 | $35.8M | Buy |
895,452
+367,863
| +70% | +$14.5M | 0.09% | 218 |
|
|
2018
Q1 | $21.1M | Buy |
+527,589
| New | +$22M | 0.05% | 307 |
|
|
2017
Q3 | – | Sell |
-56,400
| Closed | -$2.7M | – | 1223 |
|
|
2017
Q2 | $2.7M | Buy |
+56,400
| New | +$2.7M | 0.01% | 591 |
|
|
2016
Q1 | – | Sell |
-1,102,182
| Closed | -$47M | – | 1509 |
|
|
2015
Q4 | $47M | Buy |
1,102,182
+896,154
| +435% | +$41.2M | 0.22% | 105 |
|
|
2015
Q3 | $9.78M | Buy |
+206,028
| New | +$10.5M | 0.05% | 352 |
|
|
2015
Q2 | – | Sell |
-840,849
| Closed | -$41.6M | – | 1276 |
|
|
2015
Q1 | $41.6M | Sell |
840,849
-2,200,756
| -72% | -$105M | 0.26% | 97 |
|
|
2014
Q4 | $139M | Buy |
3,041,605
+901,643
| +42% | +$43.7M | 0.79% | 22 |
|
|
2014
Q3 | $121M | Buy |
2,139,962
+1,258,906
| +143% | +$67.6M | 0.65% | 34 |
|
|
2014
Q2 | $46.8M | Sell |
881,056
-537,243
| -38% | -$28.5M | 0.24% | 93 |
|
|
2014
Q1 | $74.1M | Buy |
1,418,299
+191,603
| +16% | +$9.7M | 0.45% | 53 |
|
|
2013
Q4 | $65.8M | Sell |
1,226,696
-786,755
| -39% | -$40.6M | 0.36% | 78 |
|
|
2013
Q3 | $102M | Sell |
2,013,451
-302,147
| -13% | -$15.4M | 0.65% | 38 |
|
|
2013
Q2 | $119M | Buy |
+2,315,598
| New | +$123M | 0.89% | 24 |
|
Other funds holding SNY
MIP
Arrowstreet Capital's SNY Position: Q1 2026 in Review
Arrowstreet Capital reduced its Sanofi (SNY) stake by 26% in Q1 2026, selling an estimated $1.37M and leaving 84,435 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1217.
Arrowstreet Capital first reported a position in SNY in Q2 2013 and has held it in 42 quarters since. The position peaked at $188M in Q2 2022. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Arrowstreet Capital held 84,435 shares of Sanofi worth $4.07M as of Q1 2026.
- Arrowstreet Capital sold 29,417 Sanofi shares in Q1 2026, an estimated $1.37M.
- Sanofi made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1217 holding.
- Arrowstreet Capital first reported a position in Sanofi in Q2 2013 and has held it in 42 quarters since.
- Arrowstreet Capital's Sanofi position peaked at $188M in Q2 2022.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.